BG103933A - 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate - Google Patents
5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleateInfo
- Publication number
- BG103933A BG103933A BG103933A BG10393399A BG103933A BG 103933 A BG103933 A BG 103933A BG 103933 A BG103933 A BG 103933A BG 10393399 A BG10393399 A BG 10393399A BG 103933 A BG103933 A BG 103933A
- Authority
- BG
- Bulgaria
- Prior art keywords
- ethyl
- methyl
- tetrazol
- tetrahydropyridine
- maleate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 | ||
| PCT/DK1998/000294 WO1999001448A1 (en) | 1997-07-01 | 1998-07-01 | 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG103933A true BG103933A (en) | 2000-07-31 |
Family
ID=8097489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103933A BG103933A (en) | 1997-07-01 | 1999-11-30 | 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (xx) |
| JP (1) | JP2002507215A (xx) |
| KR (1) | KR20010014297A (xx) |
| CN (1) | CN1261361A (xx) |
| AR (1) | AR013096A1 (xx) |
| AU (1) | AU735751B2 (xx) |
| BG (1) | BG103933A (xx) |
| BR (1) | BR9810331A (xx) |
| CA (1) | CA2293324A1 (xx) |
| CO (1) | CO4940483A1 (xx) |
| EA (1) | EA200000081A1 (xx) |
| HU (1) | HUP0002876A2 (xx) |
| IL (1) | IL133093A0 (xx) |
| IS (1) | IS5278A (xx) |
| JO (1) | JO2031B1 (xx) |
| MA (1) | MA25138A1 (xx) |
| NO (1) | NO996580D0 (xx) |
| PE (1) | PE116099A1 (xx) |
| PL (1) | PL337184A1 (xx) |
| SK (1) | SK187399A3 (xx) |
| TN (1) | TNSN98120A1 (xx) |
| TR (1) | TR199903283T2 (xx) |
| UY (2) | UY25069A1 (xx) |
| WO (1) | WO1999001448A1 (xx) |
| ZA (1) | ZA985498B (xx) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| WO1997017074A1 (en) * | 1995-11-06 | 1997-05-15 | H. Lundbeck A/S | Treatment of traumatic brain injury |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/es not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/xx unknown
- 1998-06-25 PE PE1998000563A patent/PE116099A1/es not_active Application Discontinuation
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-26 CO CO98036576A patent/CO4940483A1/es unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/es not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/fr unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/ko not_active Application Discontinuation
- 1998-07-01 EA EA200000081A patent/EA200000081A1/ru unknown
- 1998-07-01 CN CN98806497A patent/CN1261361A/zh active Pending
- 1998-07-01 SK SK1873-99A patent/SK187399A3/sk unknown
- 1998-07-01 EP EP98930655A patent/EP0994869A1/en not_active Withdrawn
- 1998-07-01 JP JP50616699A patent/JP2002507215A/ja active Pending
- 1998-07-01 MA MA25155A patent/MA25138A1/fr unknown
- 1998-07-01 PL PL98337184A patent/PL337184A1/xx unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/xx unknown
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/hu unknown
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/pt not_active Application Discontinuation
- 1998-07-01 CA CA002293324A patent/CA2293324A1/en not_active Abandoned
- 1998-07-01 IL IL13309398A patent/IL133093A0/xx unknown
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/en not_active Application Discontinuation
- 1998-09-10 UY UY25177A patent/UY25177A1/es not_active Application Discontinuation
-
1999
- 1999-11-30 IS IS5278A patent/IS5278A/is unknown
- 1999-11-30 BG BG103933A patent/BG103933A/xx unknown
- 1999-12-30 NO NO996580A patent/NO996580D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9810331A (pt) | 2000-09-05 |
| EP0994869A1 (en) | 2000-04-26 |
| CN1261361A (zh) | 2000-07-26 |
| UY25177A1 (es) | 2000-12-29 |
| MA25138A1 (fr) | 2001-04-02 |
| HUP0002876A2 (hu) | 2001-06-28 |
| IS5278A (is) | 1999-11-30 |
| AU735751B2 (en) | 2001-07-12 |
| EA200000081A1 (ru) | 2000-08-28 |
| PL337184A1 (en) | 2000-08-14 |
| KR20010014297A (ko) | 2001-02-26 |
| AU8102098A (en) | 1999-01-25 |
| SK187399A3 (en) | 2000-06-12 |
| PE116099A1 (es) | 1999-11-23 |
| IL133093A0 (en) | 2001-03-19 |
| NO996580L (no) | 1999-12-30 |
| TNSN98120A1 (fr) | 2005-03-15 |
| CA2293324A1 (en) | 1999-01-14 |
| ZA985498B (en) | 1999-01-20 |
| CO4940483A1 (es) | 2000-07-24 |
| AR013096A1 (es) | 2000-12-13 |
| WO1999001448A1 (en) | 1999-01-14 |
| JP2002507215A (ja) | 2002-03-05 |
| UY25069A1 (es) | 1998-12-21 |
| JO2031B1 (en) | 1999-05-15 |
| NO996580D0 (no) | 1999-12-30 |
| TR199903283T2 (xx) | 2000-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69528823D1 (en) | Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten | |
| MXPA04002982A (es) | Derivados de pirrolidinona. | |
| CA2297911A1 (en) | Substituted 6-phenylphenanthridines | |
| IL99912A0 (en) | Cyclosporins,their preparation and pharmaceutical compositions containing them | |
| EP2767291A3 (en) | Treatment of glycogen storage disease type II | |
| LU91758I9 (xx) | ||
| HK1033582A1 (en) | Antibodies to death receptor 4 (dr4) and uses thereof | |
| JO3404B1 (ar) | تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين | |
| WO2001081347A3 (en) | Diazabicyclic central nervous system active agents | |
| EP1808177A3 (en) | Methods of treatment of mitochondrial disorders | |
| TR200000015T2 (tr) | Bileşikler ve metodlar | |
| HUT73807A (en) | 5-ht1-like indole derivatives and pharmaceutical compositions containing them | |
| CA2250569A1 (en) | Novel phenanthridines substituted in the 6 position | |
| IL146448A0 (en) | Dr4 antibodies and uses thereof | |
| AU1753699A (en) | Application of vasopressin antagonists for treating disturbances or illnesses ofthe inner ear | |
| CA2058592A1 (en) | Antibacterial agents | |
| YU13301A (sh) | Muskarinski agonisti i antagonisti | |
| BG105761A (en) | Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents | |
| CA2161533A1 (en) | Indole Derivatives | |
| WO2001010408A3 (de) | Wässrige arzneimittelformulierung von moxifloxacin oder salzen davon | |
| KR100292396B1 (xx) | ||
| IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
| AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
| BG103933A (en) | 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate | |
| AP2000001946A0 (en) | Form V1 5,6-Dichloro-2-(isopropylamino)-1-(B-L-Ribofuranosyl)-1H- benzimidazole. |